Astria Therapeutics Inc (ATXS)
9.47
+0.46
(+5.11%)
USD |
NASDAQ |
May 31, 16:00
9.47
0.00 (0.00%)
After-Hours: 20:00
Astria Therapeutics Enterprise Value: 245.44M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 245.44M |
| May 30, 2024 | 220.18M |
| May 29, 2024 | 217.99M |
| May 28, 2024 | 222.38M |
| May 24, 2024 | 220.73M |
| May 23, 2024 | 220.73M |
| May 22, 2024 | 225.68M |
| May 21, 2024 | 230.62M |
| May 20, 2024 | 252.03M |
| May 17, 2024 | 249.29M |
| May 16, 2024 | 243.25M |
| May 15, 2024 | 234.46M |
| May 14, 2024 | 246.54M |
| May 13, 2024 | 258.62M |
| May 10, 2024 | 259.72M |
| May 09, 2024 | 283.88M |
| May 08, 2024 | 250.94M |
| May 07, 2024 | 273.45M |
| May 06, 2024 | 261.92M |
| May 03, 2024 | 249.84M |
| May 02, 2024 | 238.85M |
| May 01, 2024 | 247.09M |
| April 30, 2024 | 229.52M |
| April 29, 2024 | 227.87M |
| April 26, 2024 | 219.63M |
| Date | Value |
|---|---|
| April 25, 2024 | 228.97M |
| April 24, 2024 | 219.63M |
| April 23, 2024 | 254.78M |
| April 22, 2024 | 263.57M |
| April 19, 2024 | 260.82M |
| April 18, 2024 | 304.20M |
| April 17, 2024 | 304.75M |
| April 16, 2024 | 334.95M |
| April 15, 2024 | 323.42M |
| April 12, 2024 | 319.03M |
| April 11, 2024 | 343.74M |
| April 10, 2024 | 338.80M |
| April 09, 2024 | 356.37M |
| April 08, 2024 | 351.31M |
| April 05, 2024 | 344.17M |
| April 04, 2024 | 359.00M |
| April 03, 2024 | 389.74M |
| April 02, 2024 | 428.18M |
| April 01, 2024 | 467.16M |
| March 28, 2024 | 621.56M |
| March 27, 2024 | 595.48M |
| March 26, 2024 | 591.63M |
| March 25, 2024 | 658.61M |
| March 22, 2024 | 679.48M |
| March 21, 2024 | 726.69M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-106.17M
Minimum
May 13 2021
765.13M
Maximum
Mar 19 2024
100.97M
Average
62.70M
Median
Sep 29 2020
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 4.387M |
| Palatin Technologies Inc | 19.03M |
| iBio Inc | 28.91M |
| Theriva Biologics Inc | -10.98M |
| Oragenics Inc | 8.699M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -19.93M |
| Total Expenses (Quarterly) | 24.15M |
| EPS Diluted (Quarterly) | -0.38 |
| Earnings Yield | -25.34% |